Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study

M.C. Trojani, D. Gensburger, F. Bagouet,B. Cortet, G. Couture, C. Marcelli,N. Mehsen Cetre,V. Breuil,R. Chapurlat

Bone（2023）

引用 3|浏览2

暂无评分

摘要

•Denosumab significantly reduces pain in bisphosphonate resistant FD/MAS.•Denosumab is well tolerated in adults with FD/MAS.•A persistent tumoral volume decrease was observed in one patient with craniofacial FD.

查看译文

关键词

Fibrous dysplasia,Pain,Denosumab,RANKL

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要